Stock Market News, Latest Stock News
The Swiss-based clinical-stage drug developer announced the Food and Drug Administration placed a clinical hold on the clinical trials of PHA121 in the U.S. The automaker will inform affected employees in the United States, Canada and at Ford Business Solutions